{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:00:29Z","timestamp":1778778029958,"version":"3.51.4"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"DOI":"10.1590\/0037-8682-0152-2023","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T11:07:32Z","timestamp":1695380852000},"source":"Crossref","is-referenced-by-count":1,"title":["Frequency And Factors Associated With Adverse Reactions After Administration of Inactivated COVID-19 Vaccine Among Health Workers"],"prefix":"10.1590","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7126-0024","authenticated-orcid":false,"given":"Beray Gelmez","family":"Ta\u015f","sequence":"first","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0055-7186","authenticated-orcid":false,"given":"\u0130lknur","family":"Demir","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6952-4887","authenticated-orcid":false,"given":"Muhammed","family":"Basanmay","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7730-2929","authenticated-orcid":false,"given":"G\u00fczin Zeren","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3555-683X","authenticated-orcid":false,"given":"Besteg\u00fcl \u00c7oruh","family":"Akyol","sequence":"additional","affiliation":[{"name":"Ordu University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3346-8262","authenticated-orcid":false,"given":"Merve Hicret","family":"Tekta\u015f","sequence":"additional","affiliation":[{"name":"Sapanca Public Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-3605","authenticated-orcid":false,"given":"Hac\u0131 Mustafa","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2023]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5505\/amj.2020.92679","article-title":"Covid-19 In Primary Healthcare","volume":"20","author":"Acar H","year":"2020","journal-title":"Ankara Med J"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.vaccine.2021.11.091","article-title":"Adverse event of Sinovac Coronavirus vaccine: Deafness","volume":"40","author":"Zhao H","year":"2022","journal-title":"Vaccine"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10900-020-00950-5","article-title":"Evaluation of Job Strain of Family Physicians in COVID-19 Pandemic Period- An Example from Turkey","volume":"46","author":"Ta\u015f BG","year":"2021","journal-title":"J Community Health"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4274\/hamidiyemedj.galenos.2021.83703","article-title":"Evaluation of Knowledge, Practices, and Attitudes Towards Coronavirus in Individuals Aged 20-64 Years","volume":"3","author":"Ta\u015f BG","year":"2022","journal-title":"Hamidiye Med J"},{"key":"ref5","series-title":"Curfew Circular for 65 Years and Over and Those with Chronic Disorders","year":"2023"},{"key":"ref6","first-page":"1","article-title":"Eicacy and safety of COVID-19 vaccines (Review)","author":"Gra\u00f1a C","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"585354","DOI":"10.3389\/fimmu.2020.585354","article-title":"A Review of the Progress and Challenges of Developing a Vaccine for COVID-19","volume":"11","author":"Sharma O","year":"2019","journal-title":"Front Immunol"},{"key":"ref8","series-title":"COVID-19 vaccines","year":"2023"},{"key":"ref9","series-title":"Sinovac: CoronaVac - COVID19 Vaccine Tracker","year":"2023"},{"key":"ref10","series-title":"Development of an Inactivated Vaccine Candidate for SARS-CoV-2","author":"Gao Q"},{"key":"ref11","article-title":"Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac","author":"Wilder-Smith A","year":"2022","journal-title":"WHO"},{"issue":"4","key":"ref12","first-page":"683","article-title":"Two large-scale global studies on COVID-19 vaccine hesitancy over time: Culture, uncertainty avoidance, and vaccine side-effect concerns","volume":"124","author":"Lu JG","year":"2022","journal-title":"J Pers Soc Psychol"},{"key":"ref13","series-title":"COVID-19 Vaccine National Implementation Strategy","author":"Health Republic of Turkey Ministry of","year":"2023"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41590-017-0007-9","article-title":"Emerging viral diseases from a vaccinology perspective: Preparing for the next pandemic review-article","volume":"19","author":"Graham BS","year":"2018","journal-title":"Nat Immunol"},{"issue":"368","key":"ref15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"6494","author":"Graham BS","year":"2020","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0209-2022","article-title":"Humoral responses to the CoronoVac vaccine in healthcare workers","volume":"56","author":"Eyupoglu G","year":"2023","journal-title":"Rev Soc Bras Med Trop"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2020.15543","article-title":"Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials","volume":"324","author":"Xia S","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"10262","key":"ref18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland GA","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3390\/jcm10122629","article-title":"Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey","volume":"10","author":"Riad A","year":"2021","journal-title":"J Clin Med"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein SL","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"7830","key":"ref21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan MJ","year":"2020","journal-title":"Nature"},{"issue":"20","key":"ref22","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"mRNA Vaccine against SARS-CoV-2 - Preliminary Report","volume":"383","author":"Walsh EE","year":"2020","journal-title":"N Engl J Med"},{"issue":"10249","key":"ref23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Zhang Y","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang M-X","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"10249","key":"ref25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Tanriover MD","year":"2020","journal-title":"Lancet"},{"issue":"25","key":"ref26","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates","volume":"383","author":"Palacios R","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/14760584.2021.1925112","article-title":"Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China","volume":"20","author":"Zhang MX","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"0","key":"ref28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover MD","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13063-020-04775-4","article-title":"Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - Profiscov: A structured summary of a","volume":"21","author":"Palacios R","year":"2020","journal-title":"Trials"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3822780","article-title":"Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study","author":"Palacios R","year":"2021","journal-title":"SSRN Electron J"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1590\/1806-9282.20221035","article-title":"Evaluation of patients of vaccine side effects after the COVID-19 vaccine","volume":"69","author":"Semih Gedik M","year":"2023","journal-title":"Rev Assoc Med Bras"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/jocd.15573","article-title":"Cutaneous reactions after CoronaVac and BioNTech vaccines","volume":"22","author":"\u00d6ner \u00dc","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"ref33","first-page":"198","article-title":"A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?","volume":"10","author":"Aksu SB","year":"2021","journal-title":"Cl\u0131n\u0131cal Exper\u0131mental Vacc\u0131ne Res"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0037-86822023000100327&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T14:52:10Z","timestamp":1696603930000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822023000100327&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":33,"alternative-id":["S0037-86822023000100327"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0152-2023","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"value":"1678-9849","type":"electronic"},{"value":"0037-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e0152-2023"}}